137 related articles for article (PubMed ID: 14510393)
21. Synthesis and properties of RNA analogs-oligoribonucleotide N3'-->P5' phosphoramidates.
Matray TJ; Gryaznov SM
Nucleic Acids Res; 1999 Oct; 27(20):3976-85. PubMed ID: 10497261
[TBL] [Abstract][Full Text] [Related]
22. Telomerase inhibitors--oligonucleotide phosphoramidates as potential therapeutic agents.
Gryaznov S; Pongracz K; Matray T; Schultz R; Pruzan R; Aimi J; Chin A; Harley C; Shea-Herbert B; Shay J; Oshima Y; Asai A; Yamashita Y
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):401-10. PubMed ID: 11563055
[TBL] [Abstract][Full Text] [Related]
23. New Oligonucleotide 2'-O-Alkyl N3'→P5' (Thio)-Phosphoramidates as Potent Antisense Agents: Physicochemical Properties and Biological Activity.
Martínez-Montero S; Rajwanshi VK; Pandey RK; De Costa NTS; Hong J; Beigelman L; Gryaznov SM; Pourshahian S
Nucleic Acid Ther; 2023 Oct; 33(5):319-328. PubMed ID: 37638793
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of oligodeoxyribonucleotide N3'-->P5' phosphoramidates.
Chen JK; Schultz RG; Lloyd DH; Gryaznov SM
Nucleic Acids Res; 1995 Jul; 23(14):2661-8. PubMed ID: 7651827
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and properties of a novel bridged nucleic acid with a P3' --> N5' phosphoramidate linkage, 5'-amino-2',4'-BNA.
Obika S; Nakagawa O; Hiroto A; Hari Y; Imanishi T
Chem Commun (Camb); 2003 Sep; (17):2202-3. PubMed ID: 13678201
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of N3'-P5'-linked phosphoramidate DNA by nonenzymatic template-directed primer extension.
Zhang S; Zhang N; Blain JC; Szostak JW
J Am Chem Soc; 2013 Jan; 135(2):924-32. PubMed ID: 23252395
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and properties of a novel bridged nucleic acid analogue, 5'-amino-3',5'-BNA.
Sekiguchi M; Obika S; Somjing R; Imanishi T
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):1097-100. PubMed ID: 16248099
[TBL] [Abstract][Full Text] [Related]
28. NMR solution structure of the N3' --> P5' phosphoramidate duplex d(CGCGAATTCGCG)2 by the iterative relaxation matrix approach.
Ding D; Gryaznov SM; Wilson WD
Biochemistry; 1998 Sep; 37(35):12082-93. PubMed ID: 9724520
[TBL] [Abstract][Full Text] [Related]
29. Synthetic oligonucleotides as RNA mimetics: 2'-modified Rnas and N3'-->P5' phosphoramidates.
Egli M; Gryaznov SM
Cell Mol Life Sci; 2000 Sep; 57(10):1440-56. PubMed ID: 11078022
[TBL] [Abstract][Full Text] [Related]
30. Synergistic stabilization of triplex by combination of comb-type cationic copolymer and oligo-N3'-->P5' phosphoramidates.
Torigoe H; Akaike T; Maruyama A
Nucleic Acids Res Suppl; 2001; (1):195-6. PubMed ID: 12836331
[TBL] [Abstract][Full Text] [Related]
31. A phosphoramidate substrate analog is a competitive inhibitor of the Tetrahymena group I ribozyme.
Hanna RL; Gryaznov SM; Doudna JA
Chem Biol; 2000 Nov; 7(11):845-54. PubMed ID: 11094338
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of phosphoramidate-linked DNA by a modified DNA polymerase.
Lelyveld VS; Zhang W; Szostak JW
Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7276-7283. PubMed ID: 32188786
[TBL] [Abstract][Full Text] [Related]
33. Zwitterionic oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and properties.
Mignet N; Gryaznov SM
Nucleic Acids Res; 1998 Jan; 26(2):431-8. PubMed ID: 9421496
[TBL] [Abstract][Full Text] [Related]
34. Stable triple helices formed by oligonucleotide N3'-->P5' phosphoramidates inhibit transcription elongation.
Escudé C; Giovannangeli C; Sun JS; Lloyd DH; Chen JK; Gryaznov SM; Garestier T; Hélène C
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4365-9. PubMed ID: 8633072
[TBL] [Abstract][Full Text] [Related]
35. Structural RNA mimetics: N3'-->P5' phosphoramidate DNA analogs of HIV-1 RRE and TAR RNA form A-type helices that bind specifically to Rev and Tat-related peptides.
Rigl CT; Lloyd DH; Tsou DS; Gryaznov SM; Wilson WD
Biochemistry; 1997 Jan; 36(3):650-9. PubMed ID: 9012680
[TBL] [Abstract][Full Text] [Related]
36. Analysis of an oligonucleotide N3'-->P5' phosphoramidate/phosphorothioate chimera with capillary gel electrophoresis.
DeDionisio LA; Raible AM; Nelson JS
Electrophoresis; 1998 Nov; 19(16-17):2935-8. PubMed ID: 9870392
[TBL] [Abstract][Full Text] [Related]
37. Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription.
Boulmé F; Freund F; Moreau S; Nielsen PE; Gryaznov S; Toulmé JJ; Litvak S
Nucleic Acids Res; 1998 Dec; 26(23):5492-500. PubMed ID: 9826777
[TBL] [Abstract][Full Text] [Related]
38. Adjustment of the gamma dihedral angle of an oligonucleotide P3'-->N5' phosphoramidate enhances its binding affinity towards complementary strands.
Obika S; Sekiguchi M; Somjing R; Imanishi T
Angew Chem Int Ed Engl; 2005 Mar; 44(13):1944-7. PubMed ID: 15678433
[No Abstract] [Full Text] [Related]
39. A simple nucleic acid alternative: aminopropyl nucleic acids (APNAs).
Zhou D; Schepers G; Van Aerschot A
Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1665-8. PubMed ID: 18066848
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and properties of 2'-O,4'-C-methyleneoxymethylene bridged nucleic acid.
Hari Y; Obika S; Ohnishi R; Eguchi K; Osaki T; Ohishi H; Imanishi T
Bioorg Med Chem; 2006 Feb; 14(4):1029-38. PubMed ID: 16213732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
